Phase II trial of concomitant low-dose temozolomide with radiation therapy (RT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Updated results of RTOG 04-20

cited authors

  • Lieberman, Frank; Moughan, Jennifer; Tsein, Christina; Curran, Walter; Werner-Wasik, Maria; Smith, Ryan; Grossheim, Linda; Hug, Eugen; Robins, Ian; Mehta, Minesh

keywords

  • Clinical Neurology
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

WoS ID

  • 000249999100240

start page

  • 528

end page

  • 528

volume

  • 9

issue

  • 4